Kala Pharmaceuticals, Inc. (NASDAQ:KALA – Get Rating) shares shot up 3.1% during mid-day trading on Monday . The stock traded as high as $15.97 and last traded at $15.80. Approximately 78,700 shares traded hands during trading, a decline of 92% from the average daily volume of 937,802 shares. The stock had previously closed at $15.32. […]
Kala Pharmaceuticals (NASDAQ:KALA – Get Rating) had its price objective cut by analysts at HC Wainwright from $4.00 to $2.50 in a research note issued on Monday, MarketBeat reports. The brokerage currently has a “buy” rating on the stock. Separately, Wedbush dropped their price objective on shares of Kala Pharmaceuticals from $6.00 to $3.00 and […]